190 related articles for article (PubMed ID: 20339956)
1. Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology.
Xie W; Tang X; Lu Q; Ames RS; Ratcliffe SJ; Li H
Mol Biotechnol; 2010 Jul; 45(3):207-17. PubMed ID: 20339956
[TBL] [Abstract][Full Text] [Related]
2. Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase.
Lee KS; Morisseau C; Yang J; Wang P; Hwang SH; Hammock BD
Anal Biochem; 2013 Mar; 434(2):259-68. PubMed ID: 23219719
[TBL] [Abstract][Full Text] [Related]
3. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
[TBL] [Abstract][Full Text] [Related]
4. Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.
Pallàs M; Vázquez S; Sanfeliu C; Galdeano C; Griñán-Ferré C
Biomolecules; 2020 May; 10(5):. PubMed ID: 32369955
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
Revermann M
Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
[TBL] [Abstract][Full Text] [Related]
6. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.
Fang X; Kaduce TL; Weintraub NL; Harmon S; Teesch LM; Morisseau C; Thompson DA; Hammock BD; Spector AA
J Biol Chem; 2001 May; 276(18):14867-74. PubMed ID: 11278979
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
Revermann M; Barbosa-Sicard E; Dony E; Schermuly RT; Morisseau C; Geisslinger G; Fleming I; Hammock BD; Brandes RP
J Hypertens; 2009 Feb; 27(2):322-31. PubMed ID: 19226702
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase dimerization is required for hydrolase activity.
Nelson JW; Subrahmanyan RM; Summers SA; Xiao X; Alkayed NJ
J Biol Chem; 2013 Mar; 288(11):7697-7703. PubMed ID: 23362272
[TBL] [Abstract][Full Text] [Related]
9. Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors.
Schebb NH; Huby M; Morisseau C; Hwang SH; Hammock BD
Anal Bioanal Chem; 2011 May; 400(5):1359-66. PubMed ID: 21479549
[TBL] [Abstract][Full Text] [Related]
10. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
11. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
12. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
13. Measurement of soluble epoxide hydrolase (sEH) activity.
Morisseau C; Hammock BD
Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.23. PubMed ID: 23045145
[TBL] [Abstract][Full Text] [Related]
14. Protection of salvianolic acid A on rat brain from ischemic damage via soluble epoxide hydrolase inhibition.
Wang SB; Pang XB; Zhao Y; Wang YH; Zhang L; Yang XY; Fang LH; Du GH
J Asian Nat Prod Res; 2012; 14(11):1084-92. PubMed ID: 23106500
[TBL] [Abstract][Full Text] [Related]
15. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Zhang D; Xie X; Chen Y; Hammock BD; Kong W; Zhu Y
Circ Res; 2012 Mar; 110(6):808-17. PubMed ID: 22354938
[TBL] [Abstract][Full Text] [Related]
17. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
[TBL] [Abstract][Full Text] [Related]
18. Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.
Liu L; Puri N; Raffaele M; Schragenheim J; Singh SP; Bradbury JA; Bellner L; Vanella L; Zeldin DC; Cao J; Abraham NG
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():1-8. PubMed ID: 30041041
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
20. Bacterial Expression and HTS Assessment of Soluble Epoxide Hydrolase Phosphatase.
Klingler FM; Wolf M; Wittmann S; Gribbon P; Proschak E
J Biomol Screen; 2016 Aug; 21(7):689-94. PubMed ID: 27009944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
